Olian Judy D.'s Form 4 filing
United Therapeutics Corp (UTHR) · filed May 6, 2024
- Accession no.
- 0001415889-24-012330
- Filed
- May 6, 2024
- Trade date
- May 3, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.59M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olian Judy D.CIK 0001605729 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $175.43 | +$1,754,300 | 17,305 | Direct | |
| May 3, 2024 | Common Stock | SSaleDisposed | −1,228 | $256.64F1 | −$315,153.92 | 16,077 | Direct | |
| May 3, 2024 | Common Stock | SSaleDisposed | −1,829 | $257.89F2 | −$471,680.81 | 14,248 | Direct | |
| May 3, 2024 | Common Stock | SSaleDisposed | −5,616 | $258.90F3 | −$1,453,982.4 | 8,632 | Direct | |
| May 3, 2024 | Common Stock | SSaleDisposed | −1,157 | $259.70F4 | −$300,472.9 | 7,475 | Direct | |
| May 3, 2024 | Common Stock | SSaleDisposed | −170 | $260.77 | −$44,330.9 | 7,305 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $256.25 to $257.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $257.33 to $258.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $258.455 to $259.445. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $259.455 to $260.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.